President signs health legislation to combat Alzheimer's disease at close of 115th Congress
Upcoming Events
Related News
Key Takeaways
On December 31, President Trump signed into law the Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer’s Act (H.R. 4256/S. 2076), a bipartisan bill aimed at the prevention and treatment of Alzheimer’s disease. The NACo-supported bill authorizes $20 million annually for FY 2020 through FY 2024 to promote brain health activities under the Centers for Disease Control and Prevention’s (CDC) Alzheimer’s Disease and Healthy Aging Program.
Once enacted, the legislation will create a nationwide public health infrastructure program to implement risk-reduction measures around Alzheimer’s disease. As part of this effort, the bill directs the CDC to establish Alzheimer’s Centers of Excellence at eligible organizations to increase awareness among health care professionals and assist public health departments implementing evidence-based practices that increase early detection and support care-planning for residents living with the disease.
Additionally, the Centers will be able to award cooperative agreement grants to public health departments and nonprofit organizations to improve program quality and data-reporting on Alzheimer’s. County health departments will be eligible to apply for these grants.
NACo supports increased federal resources for the prevention, treatment and care for individuals with Alzheimer’s, and signed letters of support for this bill to the U.S. House of Representatives and U.S. Senate. County leaders will continue to engage with congressional legislators to ensure counties have the resources to support the health and well-being of residents.
---
Click here to view the letter to the U.S. House of Representatives.
Click here to view the letter to the U.S. Senate.
Click here to view NACo’s 2019 legislative priorities.
Attachments
Related News
HALT Fentanyl Act signed into law
On July 16, the Halt All Lethal Trafficking of Fentanyl Act (HALT Fentanyl Act) (P.L. 119-26) was signed into law, marking a major turning point in the nation’s response to the opioid epidemic. The bipartisan legislation permanently classifies fentanyl-related substances (FRS) as Schedule I drugs under the Controlled Substances Act, granting law enforcement the authority to combat the growing threat posed by synthetic opioids. The law’s enactment follows years of temporary extensions that placed these substances under federal control on a provisional basis.
Public-private partnership creates ‘one-stop shop’ to improve community wellness
The South Philadelphia Community Health and Literacy Center is a “one-stop shop” the city and the children’s hospital created to improve community wellness and make it easier for people to get their needs met.